BFC Planning’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25K Hold
15
– – ﹤0.01% 3119
2026
Q2
$1.43K Hold
15
– – ﹤0.01% 3065
2026
Q1
$736 Hold
15
– – ﹤0.01% 2796
2025
Q4
$455 Hold
15
– – ﹤0.01% 2944
2025
Q3
$288 Hold
15
– – ﹤0.01% 2799
2025
Q2
$168 Hold
15
– – ﹤0.01% 2611
2025
Q1
$154 Hold
15
– – ﹤0.01% 2593
2024
Q4
$291 Hold
15
– – ﹤0.01% 2512
2024
Q3
$368 Buy
+15
New +$522 ﹤0.01% 2497

Other funds holding ORKA

BFC Planning's ORKA Position: Q3 2026 in Review

BFC Planning held its Oruka Therapeutics (ORKA) position steady in Q3 2026 at 15 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

BFC Planning first reported a position in ORKA in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.43K in Q2 2026. 175 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • BFC Planning held 15 shares of Oruka Therapeutics worth $1.25K as of Q3 2026.
  • BFC Planning left its Oruka Therapeutics share count unchanged in Q3 2026.
  • Oruka Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3119 holding.
  • BFC Planning first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Oruka Therapeutics position peaked at $1.43K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.